Uncategorized L-form switching in E. coli: Interesting report! 27 Jun 2021 A new preprint article "L-form switching confers antibiotic, phage and stress tolerance in pathogenic Escherichia coli" reports the importance of bacterial cell wall in adaptation. Abstract: The bacterial L-form is…
Uncategorized Increasing Demand for Phage Probiotics 23 Jun 2021 Bacteriophage market is gaining pace owing to the rising demand for treatment of antibacterial-resistant infections Fact.MR, Dubai: The global bacteriophage market has witnessed impressive growth with revenue surpassing US$ 39…
Uncategorized Bacteria Hijack Latent Phage Of Competitor 21 Jun 2021 Bacteriophages are still a relatively unknown component of the human microbiome. However, they can play a powerful role in the life cycles of bacteria. Biochemist Thomas Böttcher from the University…
Uncategorized Editor: Book chapters are invited in ‘Bacteriophage Research’ 17 Jun 2021 In a new role: Editor of the forthcoming book on "Bacteriophages: Interaction, Replication and Diversity" published by Nova Science Publishers Inc., NY. I'm inviting book chapters from the experts and…
Uncategorized People who travel abroad can unknowingly spread antibiotic resistance 13 Jun 2021 People in the Netherlands who travel abroad are unknowingly contributing to the rise of antibiotic resistance by picking up gut bacteria containing drug-resistance genes while overseas then returning home. The same is…
Uncategorized New Role, Associate Editor in BMC Microbiology 11 Jun 2021 Happy to let you all know that I am joining as an Editorial board member in BMC journal series. https://bmcmicrobiol.biomedcentral.com/. Joining the editoral team of BMC Microbiology as an ASSOCIATE…
Uncategorized Pseudomonas aeruginosa poses a serious threat to human health 6 Jun 2021 No one knows exactly when humans and pathogenic bacteria were encountered with each other. But since then, the war began over life and survival between them. During this time, both…
Uncategorized Adaptive Phage Therapeutics Initiates Phase 1/2 Trial of PhageBank 4 Jun 2021 Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the first patient has been dosed in a Phase 1/2 study…
Uncategorized Phage Therapy: Legacy of CF Advocate Mallory Smith Endures 2 Jun 2021 The legacy of Mallory Smith, who died nearly four years ago from a cystic fibrosis-related superbug infection in her lungs, is living on in the form of raising awareness and…